Bad karma: we can't find that page!

Hansen Medical, Inc. (NASDAQ: HNSN), a global leader in intravascular robotics, announced that it will exhibit its Magellan™ Robotic System at the 2013 Vascular Annual Meeting® of the Society for Vascular Surgery from May 30 - June 1 at the Moscone West Convention Center in San Francisco, CA. The Company will be exhibiting the Magellan Robotic System and conducting product demonstrations at Booth 301.

Nephosity, a digital health startup that was a member of Rock Health’s second class, has received clearance from the United States Food and Drug Administration (FDA) for their MobileCT Viewer, a software application for diagnostic image viewing on the iPad.

Nephosity, Inc. builds the platform for anywhere, anytime medical image viewing, sharing, and collaboration, improving the medical imaging workflow for physicians and other healthcare providers, which lowers costs, engages patients, and improves care. This FDA 510(k) clearance reaffirms the quality and safety of MobileCT Viewer, and allows for diagnostic viewing of CT, MRI, and X-ray medical images by trained professionals on the iPad in situations where there is no access to a workstation.

Representing the interests of the 240,000 American men who are at risk each year for a diagnosis of prostate cancer, and the over 2 million men living today who have been diagnosed with this deadly form of cancer, the membership of the Prostate Cancer Roundtable is increasingly concerned by the utterly confusing guidance being offered – to both the professional healthcare community and to individual consumers -- about whether men should or should not be tested ("screened") for risk of prostate cancer.

ORBIT II trial met primary endpoints treating patient population in which 99.3% of subjects had severely calcified lesions
30-day freedom from MACE rate of 89.8 percent
Procedural success of 89.1 percent (including in-hospital MACE)

New data shows:
92.8% of patients experienced no severe angiographic complications at 30 days
4.7% final procedure mean residual stenosis (core lab assessed)

New techniques in imaging of brain activity developed by Jean Gotman, from McGill University's Montreal Neurological Institute, and his colleagues lead to improved treatment of patients suffering from epilepsy. The combination of electroencephalogram (EEG) and functional magnetic resonance imaging (fMRI) leads to more precise localization of the areas generating epileptic seizures, giving neurosurgeons a better understanding of the optimal ways of intervention, if appropriate. These results were presented at the 2013 Canadian Neuroscience Meeting, the annual meeting of the Canadian Association for Neuroscience - Association Canadienne des Neurosciences (CAN-ACN).